Copyright
©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 14, 2005; 11(34): 5342-5346
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5342
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5342
High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy
Holger G. Hass, Stephan Kaiser, Department of Gastroenterology and Hepatology, University of Tuebingen, Germany
Christian Kreysel, Department of Gastroenterology, Klinikum Krefeld, Germany
Johannes Fischinger, Department of Gastroenterology and Hepatology, University of Saarland, Germany
Josef Menzel, Department of Gastroenterology and Hepatology, University of Muenster, Germany
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Holger G. Hass, Department of Gastroenterology and Hepatology, University of Tuebingen, Otfried-Müller-Straße 10, 72076 Tübingen, Germany. holger.hass@med.uni-tuebingen.de
Telephone: +49-7071-2982712 Fax: +49-7071-293467
Received: December 12, 2004
Revised: January 1, 2005
Accepted: January 5, 2005
Published online: September 14, 2005
Revised: January 1, 2005
Accepted: January 5, 2005
Published online: September 14, 2005
Core Tip